Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2

International Journal of Oncology

Volumn 47, Issue 3, 2015, Pages 1025-1033

  Fan, Bo ^a   Jiao, Bao Hua ^a   Fan, Feng Shi ^a   Lu, Sheng Kui ^a   Song, Jian ^a   Guo, Cheng Yong ^a   Yang, Jian Kai ^a   Yang, Liang ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; CUGBP and ETR 3 like family 2; Glioma; Invasion; MiR 95 3p; Proliferation

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CELF2 PROTEIN; LUCIFERASE; MICRORNA; MICRORNA 95 3P; NUCLEIC ACID BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CELF PROTEIN; CELF2 PROTEIN, HUMAN; MIRN95 MICRORNA, HUMAN; NERVE PROTEIN;

3' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; BINDING SITE; CANCER GRADING; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLIOMA CELL LINE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; RNA ANALYSIS; TUMOR INVASION; UPREGULATION; BRAIN TUMOR; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; PROMOTER REGION; TUMOR CELL LINE;

ADULT; BINDING SITES; BRAIN NEOPLASMS; CELF PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC;

EID: 84938055256     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.3080     Document Type: Article

References (36)

1. Giese A, Bjerkvig R, Berens ME and Westphal M: Cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol 21: 1624-1636, 2003.
2. Lefranc F, Brotchi J and Kiss R: Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23: 2411-2422, 2005.
3. Singh SK, Clarke ID, Hide T and Dirks PB: Cancer stem cells in nervous system tumors. Oncogene 23: 7267-7273, 2004.
4. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al: Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710, 2007.
5. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
6. Eulalio A, Huntzinger E and Izaurralde E: Getting to the root of miRNA-mediated gene silencing. Cell 132: 9-14, 2008.
7. Carthew RW: Gene regulation by microRNAs. Curr Opin Genet Dev 16: 203-208, 2006.
8. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007.
9. Lujambio A and Lowe SW: The microcosmos of cancer. Nature 482: 347-355, 2012.
10. Bagnoli M, De Cecco L, Granata A, Nicoletti R, Marchesi E, Alberti P, Valeri B, Libra M, Barbareschi M, Raspagliesi F, et al: Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget 2: 1265-1278, 2011.
11. Iorio MV and Croce CM: microRNA involvement in human cancer. Carcinogenesis 33: 1126-1133, 2012.
12. Godlewski J, Nowicki MO, Bronisz A, Nuovo G, Palatini J, De Lay M, Van Brocklyn J, Ostrowski MC, Chiocca EA and Lawler SE: MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell 37: 620-632, 2010.
13. Gabriely G, Yi M, Narayan RS, Niers JM, Wurdinger T, Imitola J, Ligon KL, Kesari S, Esau C, Stephens RM, et al: Human glioma growth is controlled by microRNA-10b. Cancer Res 71: 3563-3572, 2011.
14. Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, et al: MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 69: 7569-7576, 2009.
15. Chan JA, Krichevsky AM and Kosik KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033, 2005.
16. Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG: Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358, 2005.
17. Zhou J, Wang W, Gao Z, Peng X, Chen X, Chen W, Xu W, Xu H, Lin MC and Jiang S: MicroRNA-155 promotes glioma cell proliferation via the regulation of MXI1. PLoS One 8: e83055, 2013.
18. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and selfrenewal. Cancer Res 68: 9125-9130, 2008.
19. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, et al: miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14, 2008.
20. Bier A, Giladi N, Kronfeld N, Lee HK, Cazacu S, Finniss S, Xiang C, Poisson L, deCarvalho AC, Slavin S, et al: MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Oncotarget 4: 665-676, 2013.
21. Skalsky RL and Cullen BR: Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene. PLoS One 6: e24248, 2011.
22. Huang Z, Huang S, Wang Q, Liang L, Ni S, Wang L, Sheng W, He X and Du X: MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. Cancer Res 71: 2582-2589, 2011.
23. Huang X, Taeb S, Jahangiri S, Emmenegger U, Tran E, Bruce J, Mesci A, Korpela E, Vesprini D, Wong CS, et al: miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1. Cancer Res 73: 6972-6986, 2013.
24. Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q and Chen C: Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg 33: 698-709, 2009.
25. Xiao Z, Ching Chow S, Han Li C, Chun Tang S, Tsui SK, Lin Z and Chen Y: Role of microRNA-95 in the anticancer activity of Brucein D in hepatocellular carcinoma. Eur J Pharmacol 728: 141-150, 2014.
26. Nurul-Syakima AM, Yoke-Kqueen C, Sabariah AR, Shiran MS, Singh A and Learn-Han L: Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers. Int J Mol Med 28: 327-336, 2011.
27. Barreau C, Paillard L, Méreau A and Osborne HB: Mammalian CELF/Bruno-like RNA-binding proteins: Molecular characteristics and biological functions. Biochimie 88: 515-525, 2006.
28. Keene JD: RNA recognition by autoantigens and autoantibodies. Mol Biol Rep 23: 173-181, 1996.
29. Ladd AN and Cooper TA: Multiple domains control the subcellular localization and activity of ETR-3, a regulator of nuclear and cytoplasmic RNA processing events. J Cell Sci 117: 3519-3529, 2004.
30. Wang GS, Kearney DL, De Biasi M, Taffet G and Cooper TA: Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J Clin Invest 117: 2802-2811, 2007.
31. Choi DK, Ito T, Mitsui Y and Sakaki Y: Fluorescent differential display analysis of gene expression in apoptotic neuroblastoma cells. Gene 223: 21-31, 1998.
32. Pershouse MA, Stubblefield E, Hadi A, Killary AM, Yung WK and Steck PA: Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res 53: 5043-5050, 1993.
33. Ransom DT, Ritland SR, Moertel CA, Dahl RJ, O'Fallon JR, Scheithauer BW, Kimmel DW, Kelly PJ, Olopade OI, Diaz MO, et al: Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosomes Cancer 5: 357-374, 1992.
34. Subramaniam D, Natarajan G, Ramalingam S, Ramachandran I, May R, Queimado L, Houchen CW and Anant S: Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2. Am J Physiol Gastrointest Liver Physiol 294: G1025-G1032, 2008.
35. Natarajan G, Ramalingam S, Ramachandran I, May R, Queimado L, Houchen CW and Anant S: CUGBP2 downregulation by prostaglandin E2 protects colon cancer cells from radiation-induced mitotic catastrophe. Am J Physiol Gastrointest Liver Physiol 294: G1235-G1244, 2008.
36. Subramaniam D, Ramalingam S, Linehan DC, Dieckgraefe BK, Postier RG, Houchen CW, Jensen RA and Anant S: RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. PLoS One 6: e16958, 2011.